| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 53327 | Null | 0.0314734733353265 | 0.19264309 |
| NSC 59220 | [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt | 0.0314734733353265 | 0.40188508 |
| NSC 623176 | Null | 0.0314734733353265 | 0.46106938 |
| NSC 624659 | ANTINEOPLASTIC-624659 | 0.0314734733353265 | 0.5400244 |
| NSC 627669 | Null | 0.0314734733353265 | 0.21539066 |
| NSC 631075 | Null | 0.0314734733353265 | 0.059593983 |
| NSC 632882 | Dicarbonyl[1-(4-cyanaphenyl-NC-azomethyine)- naphthaline-2-olato(O1,N1)]iridium(I) | 0.0314734733353265 | 0.47963464 |
| NSC 637467 | Disulfide, bis[2-amino-4-(4-methoxyphenyl)-1-methyl- 1H-imidazol-5-yl], dihydrochloride | 0.0314734733353265 | 0.16370702 |
| NSC 639186 | Raltitrexed | 0.0314734733353265 | 0.18276501 |
| NSC 659950 | 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone | 0.0314734733353265 | 0.2954637 |